Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment

We documented cognitive and speech functioning before treatment in individuals with head and neck cancer in a prospective cohort study. Results indicated a high prevalence of speech and cognitive impairment. Patient-reported speech and cognitive function were associated with each other, whereas objective cognitive measures were not associated with patient-reported measures.